HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

palomid 529

both a TORC1 and TORC2 inhibitor with antineoplastic activity; structure in first source
Also Known As:
RES-529
Networked: 13 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Sherris, David: 7 articles (06/2014 - 11/2008)
2. Festuccia, Claudio: 2 articles (06/2014 - 08/2011)
3. Gravina, Giovanni Luca: 2 articles (06/2014 - 08/2011)
4. Jannini, Emmanuele A: 2 articles (06/2014 - 08/2011)
5. Marampon, Francesco: 2 articles (06/2014 - 08/2011)
6. Tombolini, Vincenzo: 2 articles (06/2014 - 08/2011)
7. Beijnen, Jos H: 2 articles (09/2013 - 12/2011)
8. Lin, Fan: 2 articles (09/2013 - 12/2011)
9. Sherris, D: 2 articles (05/2011 - 03/2009)
10. Chen, Binjie: 1 article (01/2021)

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Neoplasms (Cancer)
3. Glioblastoma (Glioblastoma Multiforme)
4. Breast Neoplasms (Breast Cancer)
5. Carcinogenesis

Related Drugs and Biologics

1. Mechanistic Target of Rapamycin Complex 2
2. Mechanistic Target of Rapamycin Complex 1
3. TOR Serine-Threonine Kinases
4. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
5. Ribosomal Protein S6
6. Member 1 Subfamily B ATP Binding Cassette Transporter
7. Proteins (Proteins, Gene)
8. Hormones (Hormone)
9. Cisplatin (Platino)
10. Adenosine Triphosphate (ATP)

Related Therapies and Procedures

1. Radiotherapy
2. Therapeutics
3. Intraperitoneal Injections
4. Drug Therapy (Chemotherapy)